Hi!
I have a couple of questions about Flowchart F (materials change in non-IVDD device) of Health Canada Guidance for the Interpretation of Significant Change of a Medical Device.
1) is the term "contact" used in the flowchart referring to both direct and indirect?
2) if the device not intended to be absorbed by the body or to remain in the body for at least 30 consecutive days, but the altered material is in contact with body tissues or fluid, change to the "specification" has to be considered. What is your interpretation of this "specification"? Is it specification of the material or of the device or of the part?
If there is a change to the material, in which instances there will be no change to the specification?
Thank you for your help!!
I have a couple of questions about Flowchart F (materials change in non-IVDD device) of Health Canada Guidance for the Interpretation of Significant Change of a Medical Device.
1) is the term "contact" used in the flowchart referring to both direct and indirect?
2) if the device not intended to be absorbed by the body or to remain in the body for at least 30 consecutive days, but the altered material is in contact with body tissues or fluid, change to the "specification" has to be considered. What is your interpretation of this "specification"? Is it specification of the material or of the device or of the part?
If there is a change to the material, in which instances there will be no change to the specification?
Thank you for your help!!
Last edited: